Merck stock (NYSE: MRK) lost about 10% in 2024, underperforming the broader S&P 500 index, which gained 23% for the year. Despite strong performances from other pharmaceutical giants like Eli ...

In the wake of AI, unprecedented demand for data and computing power is outstripping capabilities. This will drive the ...

PepsiCo disclosed mixed fourth-quarter earnings Tuesday amid ongoing challenges in North American markets. PepsiCo’s earnings ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE ... what lies ahead for investors in 2025? What’s in Store for S&P 500 Index in 2025? Ameriprise Financial believes ...

We recently published a list of 12 Best Depressed Stocks to Invest in Now. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best depressed stocks ...

One of Milwaukee's largest Hispanic-owned grocery store chains, El Rey, is preparing for the impact of President Trump's tariffs. President Donald Trump announced new tariffs on ...

It culminated in a new CEO, and investors are waiting to see what's in store this year ... and the market is waiting for another update. Amgen, Merck, and Johnson & Johnson are all healthcare ...

Cigna forecast annual profit below Wall Street expectations on Thursday and missed estimates for the fourth quarter, hurt by higher medical costs for a type of employer-sponsored healthcare plan.

Facing intense scrutiny from senators over his potential profit from vaccine lawsuits while serving as the nation's health ...

Investment legend Peter Lynch thinks it is a mistake to time the market and run to the hills in anticipation of a correction.